Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy.

NCT00305188 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

879

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastases
Colorectal Neoplasms
Colorectal Carcinoma

Interventions

DRUG: Xaliproden (SR57746A)
DRUG: Placebo
DRUG: Oxaliplatin
DRUG: 5-Fluorouracil
DRUG: Leucovorin

Sponsor

Sanofi